Ravindre Panchia to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Ravindre Panchia has written about Reverse Transcriptase Inhibitors.
Connection Strength
0,135
-
HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial. PLoS One. 2017; 12(6):e0178594.
Score: 0,135
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.